BOHEMIA, N.Y., Jan. 7, 2003 (PRIMEZONE) -- Ms. Helena R. Santos, President and Chief Executive Officer of Scientific Industries, Inc. (OTCBB:SCND) (the Company), announced that as part of the Company's recently adopted business plan to expand its marketing and selling efforts and to develop and market new products, it has hired its first Sales and Marketing Director and has entered into a long term marketing consulting agreement with its recently elected director, Joseph G. Cremonese, a former employee of the Company's principal distributor expanding the period and duties he previously provided to the Company.
Ms. Santos also announced that, "Ms. Chere Griffin, the new Sales and Marketing Director, is well experienced in marketing products in our industry, and will devote her efforts to increasing the market and sales of the Company's products, particularly new products which were recently introduced and those which are to be introduced near term."
To secure its new management team, the Company has agreed to enter into two-year employment agreements with Ms. Santos and Mr. Robert P. Nichols, its recently appointed Executive Vice-President, both of whom were appointed to their current positions in August 2002 after having held key positions with the Company for more than five years prior thereto.
About Scientific Industries
Scientific Industries manufactures and markets laboratory equipment, including the world-renowned Vortex-Genie(r) 2 Mixer. Scientific's products are used by research laboratories, clinics, pharmaceutical manufacturers, medical device manufacturers, and other industries.
Statements made in this press release that relate to future events, performance or financial results of the Company are forward-looking statements which involve uncertainties that could cause actual events, performance or results to materially differ. The Company undertakes no obligation to update any of these statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. Accordingly, any forward-looking statement should be read in conjunction with the additional information about risks and uncertainties set forth in the Company's Securities and Exchange Commission reports, including our annual report on Form 10-KSB.